Biomea Fusion, Inc. Stock Issued During Period, Shares, Conversion of Convertible Securities
Biomea Fusion, Inc. (BMEA) had Stock Issued During Period, Shares, Conversion of Convertible Securities of 7.06 million shares as of 2021-04-19, per its 10-Q filed 2021-11-03.
Discontinued
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2021-11-03
- 2021-04-19: Stock Issued During Period, Shares, Conversion of Convertible Securities 7.06M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities |
|---|---|
| 2021-04-19 | 7.06M shares 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |